JARID2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.546600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.499000E-01
Normal-vs-Stage2
2.568200E-01
Normal-vs-Stage3
1.763970E-01
Normal-vs-Stage4
2.244600E-01
Stage1-vs-Stage2
7.770400E-01
Stage1-vs-Stage3
6.342100E-02
Stage1-vs-Stage4
4.011000E-01
Stage2-vs-Stage3
2.193600E-01
Stage2-vs-Stage4
5.368600E-01
Stage3-vs-Stage4
1.159580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.576600E-01
Normal-vs-AfricanAmerican
2.423400E-01
Normal-vs-Asian
2.176200E-01
Caucasian-vs-AfricanAmerican
7.519200E-01
Caucasian-vs-Asian
3.300400E-01
AfricanAmerican-vs-Asian
6.734400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.512000E-01
Normal-vs-Female
2.623600E-01
Male-vs-Female
6.418200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.920620E-01
Normal-vs-Age(41-60Yrs)
2.963200E-01
Normal-vs-Age(61-80Yrs)
2.341400E-01
Normal-vs-Age(81-100Yrs)
1.651580E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.169200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.439000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.306200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.924130E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.843000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.297000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.664400E-03
Normal-vs-Daily Drinker
1.909770E-01
Normal-vs-Weekly Drinker
2.194200E-01
Normal-vs-Occasional Drinker
4.763900E-02
Normal-vs-Social Drinker
2.715600E-01
Non Drinker-vs-Daily Drinker
2.165200E-01
Non Drinker-vs-Weekly Drinker
7.448200E-01
Non Drinker-vs-Occasional Drinker
1.322040E-01
Non Drinker-vs-Social Drinker
4.198800E-01
Daily Drinker-vs-Weekly Drinker
3.916600E-01
Daily Drinker-vs-Occasional Drinker
4.203600E-03
Daily Drinker-vs-Social Drinker
2.105800E-02
Weekly Drinker-vs-Occasional Drinker
7.214400E-02
Weekly Drinker-vs-Social Drinker
2.225000E-01
Occasional Drinker-vs-Social Drinker
3.724400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.015400E-01
Normal-vs-Grade 2
2.970000E-02
Normal-vs-Grade 3
8.409600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.981400E-01
Grade 1-vs-Grade 3
3.300800E-01
Grade 1-vs-Grade 4
2.015400E-01
Grade 2-vs-Grade 3
4.526200E-01
Grade 2-vs-Grade 4
2.970000E-02
Grade 3-vs-Grade 4
8.409600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.535700E-03
Normal-vs-NonDiabetic
2.356000E-01
Diabetic-vs-NonDiabetic
4.628200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.303200E-01
Normal-vs-NoPancreatitis
2.454000E-01
Pancreatitis-vs-NoPancreatitis
6.732600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.534200E-01
Normal-vs-N1
2.578200E-01
N0-vs-N1
8.618600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.830630E-01
Normal-vs-TP53-NonMutant
1.595370E-01
TP53-Mutant-vs-TP53-NonMutant
4.022000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
